Despite significant advancements, cancer research faces many challenges. Academic papers often discuss issues such as drug resistance, tumor heterogeneity, and the difficulty in translating laboratory findings to clinical success. Researchers also grapple with ethical considerations in clinical trials and the high costs associated with developing new therapies. Additionally, there is a continuous need for more comprehensive data sharing and collaboration across institutions to accelerate progress.
